- Accueil >
- Publications >
- CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
Auteurs
S Lefort, A Thuleau, Y Kieffer, P Sirven, I Bieche, E Marangoni, A Vincent-Salomon, F Mechta-Grigoriou